Search clinical trials for: PD-1 inhibitor
Total 105737 results
-
Case Comprehensive Cancer CenterCompletedMetastatic Renal Cell CancerUnited States
-
John KirkwoodBristol-Myers Squibb; Secura Bio, Inc.RecruitingUnresectable MelanomaUnited States
-
Sun Yat-sen UniversityRecruitingEsophageal Squamous Cell Carcinoma | Oligometastatic DiseaseChina
-
Shanghai Cell Therapy Research InstituteUnknownAdvanced Solid TumorChina
-
Merck Sharp & Dohme LLCActive, not recruitingBladder CancerCanada, United States, Australia, Belgium, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Sweden, Thailand, Turkey, Ukraine, United Kingdom
-
RenJi HospitalRecruitingFumarate Hydratase Deficient Renal Cell CarcinomaChina
-
Tianjin Medical University Cancer Institute and...RecruitingLocally Advanced Gastric AdenocarcinomaChina
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Peking University First HospitalYiZhou International Cancer HospitalUnknownImmunotherapy | Proton Therapy
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of CancerActive, not recruiting
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...Active, not recruitingGastric Cancer Stage IVChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Fuzhou General HospitalUnknownSmall Cell Lung Cancer | Lung Neoplasm | PD-1 InhibitorsChina
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co...UnknownSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGastric Cancer | GastroEsophageal CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell LungIndia
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Australia, Canada, Chile, China, Colombia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Hutchison Medipharma LimitedRecruiting
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Korea, Republic of, Belgium, Canada, Italy, Spain, Germany, Hong Kong, Hungary, China, Czechia, Taiwan, United States, France, Poland, Thailand, Netherlands
-
Chinese PLA General HospitalUnknownLymphoma | Solid TumorChina
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.UnknownAdvanced Solid TumorsChina
-
Xuanwu Hospital, BeijingUnknownNon-small Cell Lung Cancer | PD-1 Antibody | Lung Cancer Stage II
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Changzhou No.2 People's HospitalNot yet recruitingAdvanced Solid Tumor
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences LtdRecruitingUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, ImmunologicalChina
-
Memorial Sloan Kettering Cancer CenterXencor, Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Sun Yat-sen UniversityRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | Lenvatinib | Hepatic Arterial Infusion ChemotherapyChina
-
Peking University Third HospitalCompletedPancreatic Cancer | Stereotactic Body Radiotherapy | PD-1 InhibitorsChina
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated...RecruitingAdvanced Thyroid Cancer Patients Who Received Target TherapyChina
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.CompletedToxicity | Overall Survival | Progression-free Survival | Clinical Benefit RateChina
-
Xiaorong DongUnknown
-
Cancer Research UKHeptares Therapeutics LimitedRecruitingSarcoma | Neoplasms | Kidney Neoplasms | Uterine Cervical Neoplasms | Stomach Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Mesothelioma, Malignant | Prostatic Neoplasms, Castration-Resistant | PheochromocytomasUnited Kingdom
-
Groupe Hospitalier Pitie-SalpetriereVanderbilt University Medical Center; Vanderbilt University; Institute of Cardiometabolism...CompletedMyocarditis | Cardiac ComplicationFrance
-
Merck Sharp & Dohme LLCWithdrawn
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.CompletedCholangiocarcinoma | Biliary Tract CancerChina
-
Diwakar DavarAculeus TherapeuticsActive, not recruitingNSCLC | Metastatic Colorectal Carcinoma | Refractory MelanomaUnited States
-
Wuhan Union Hospital, ChinaRecruitingNon Small Cell Lung CancerChina
-
Centre hospitalier de l'Université de Montréal...CompletedNon-small Cell Lung Cancer Metastatic | Cryotherapy EffectCanada
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
Aiping ShiRecruitingTriple Negative Breast Cancer (TNBC)China
-
Hunan Province Tumor HospitalCompleted
-
Noscira SACompletedAlzheimer´s DiseaseGermany
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsColombia, United States, Canada, Chile, France, Germany, Hungary, Ireland, Japan, Korea, Republic of, Poland, Spain, Taiwan, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
The Affiliated Hospital of Xuzhou Medical UniversityNot yet recruitingAdvanced Solid TumorChina